Wuhan-based biotech firm subject of investigation

Chinese company and three US firms accused of importinginfringing rHSA products and false designation of origin

Ben Wodecki

A Wuhan, China-based biotech firm is among a group ofdefendants subject to an investigation from the US International TradeCommission (ITC), over allegedly importing patent infringing plant-derivedrecombinant human serum albumins (rHSA).